237_2020_01	
    			    			
                MHHi033-A            
            
        General
Cell Line | 
					|
| hPSCreg name | MHHi033-A | 
| Cite as: | MHHi033-A | 
| Alternative name(s) | 
									 
	237_2020_01	 
							 | 
						
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | No similar lines found. | 
| Last update | 27th August 2025 | 
| User feedback | |
Provider | 
					|
| Generator | 
							Hannover Medical School (MHH)														    								 
    									Contact:
    									 
    																				Berlin Institute of Health (BIH)  | 
					
| Owner | Hannover Medical School (MHH) | 
| Distributors | |
| Derivation country | Germany | 
External Databases | 
						|
| BioSamples | SAMEA117961247 | 
							    
							General Information | 
					|
| * Is the cell line readily obtainable for third parties? | 
                                     No                                                                      | 
                            
Donor Information
General Donor Information | 
					|
| Sex | male | 
Phenotype and Disease related information (Donor) | 
					|
| Diseases | A disease was diagnosed.
																	 | 
					
Karyotyping (Donor) | 
						|
| Has the donor karyotype been analysed? | 
								 Unknown 								
															 | 
						
Other Genotyping (Donor) | 
						|
| Is there genome-wide genotyping or functional data available? | 
								 No 								
															 | 
						
External Databases (Donor) | 
						|
| BioSamples | SAMEA117961249 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | No | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No | 
| If you do not hold the Donor Consent Form, do you know who does? | Yes | 
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| * Does consent expressly prevent the derivation of pluripotent stem cells? | No | 
| * Does consent pertain to a specific research project? | No | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | Yes | 
| How may genetic information associated with the cell line be accessed? | Controlled Access | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes | 
| Name of accrediting authority involved? | Medizinische Hochschule Hannover : MHH | 
| Approval number | 2200 | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | 
hIPSC Derivation
General | 
						|
| Source cell type | 
										
				
	
			 An immature, nucleated erythrocyte occupying the stage of erythropoiesis that follows formation of erythroid progenitor cells and precedes formation of reticulocytes. 
	
			Synonyms 
		
  | 
							
Reprogramming method | 
						|
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Genes | |
| Is reprogramming vector detectable? | 
										 No 									 | 
								
| Methods used | 
										 
	PCR	 
									 | 
								
| Files and images showing reprogramming vector expressed or silenced | |
Vector free reprogramming | 
						|
Other | 
						|
| Derived under xeno-free conditions | 
								 Unknown 							 | 
						
| Derived under GMP? | 
								 Unknown 							 | 
						
| Available as clinical grade? | 
								 Unknown 							 | 
						
Culture Conditions
| Surface coating | Matrigel/Geltrex | 
| Feeder cells | 
															 No 														 | 
						
| Passage method | 
								Enzyme-free cell dissociation
								
																											 
											EDTA										 
																	
							 | 
						
| O2 Concentration | 5 % | 
| CO2 Concentration | 5 % | 
| Medium | 
								Essential 8™		
		
								 | 
						
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes  | 
					
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No  | 
					
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes  | 
					
Characterisation
Analysis of Undifferentiated Cells
Morphology pictures
Differentiation Potency
In vitro directed differentiation
					| Marker | Expressed | 
| CDH5 (CD144) | 
										 Yes 					                 | 
								
| PDGFRB (CD140b) | 
										 Yes 					                 | 
								
Protocol or reference
						In vitro directed differentiation
					| Marker | Expressed | 
| PAX6 | 
										 Yes 					                 | 
								
| SOX2 | 
										 Yes 					                 | 
								
Protocol or reference
						Microbiology / Virus Screening | 
						|
| HIV 1 | Negative | 
| HIV 2 | Negative | 
| Hepatitis B | Negative | 
| Hepatitis C | Negative | 
| Mycoplasma | Negative | 
Certificate of Analysis | 
					|
| Is there a certificate of analysis available? | 
							 Yes 
														
														
								Passage:
								14							 
													 | 
					
Genotyping
Karyotyping (Cell Line) | 
					|
| Has the cell line karyotype been analysed? | 
								 Yes 								
																	
												 46,XY [cp20]
											 
																				
																					
																															
											Passage number: 15											 
																															
											Karyotyping method:
											G-Banding											
																						 
																			 | 
						
Other Genotyping (Cell Line) | 
					|

Login to share your feedback, experiences or results with the research community.